United States · FDA National Drug Code directory
Insulin Lispro
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-5391_9a40f3c1-7d33-48fd-b73b-f4d03ed24bc8
- Product NDC
- 50090-5391
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Insulin lispro
- Labeler
- A-S Medication Solutions
- Marketing category
- BLA
- Marketing start / end (source format)
- 20200212
- Source listing expiry
- 20261231
Source-listed ingredients
- INSULIN LISPRO — 100 [iU]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (50090-5391-0) / 10 mL in 1 VIAL · 50090-5391-0
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →